Last checked at 12 May 2015 07:00
12 May 2015
Genus plc
('Genus' or the 'Company')
Capital Markets Event and Trading Update
Genus, a leading global animal genetics company, today publishes a trading update for the period from 1 January 2015 to 11 May 2015.
Capital Markets Event
Genus is holding a Capital Markets Event today at 2pm at which no material new information will be disclosed and Genus will not be commenting on current trading beyond what is announced in this statement.
The Capital Markets Event will cover Genus's business model and the initiatives being implemented to further strengthen its position as a leader in the animal genetics market. The presentations given by Genus management will be made available on the Company website tomorrow.
Current Trading
Genus performed in line with expectations in the period under review. Genus's volumes, revenues and adjusted profit before tax all increased compared with last year's performance.
Outlook
Genus continued to make good progress during the period under review towards our strategic objectives, and is trading in line with expectations for the financial year 2015.
For further information please contact:
Genus plc | Tel: 01256 345970 |
Karim Bitar, Chief Executive | |
Stephen Wilson, Group Finance Director | |
Buchanan | Tel: 0207 466 5107 |
Charles Ryland /Sophie McNulty |
This announcement is available on the Genus website www.genusplc.com
About Genus
Genus creates advances to animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across all livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.
Genus's worldwide sales are made in seventy countries under the trademarks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Genus's customers' animals produce offspring with greater production efficiency, and quality, and use these to supply the global dairy and meat supply chain.
The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network.
With headquarters in Basingstoke, United Kingdom, Genus companies operate in thirty countries on six continents, with research laboratories located in Madison, Wisconsin, USA.